In MetS, Lethe lncRNAs are known to inhibit the binding of NF-κB’s p65 subunits to DNA, thus exerting anti-inflammatory effects by inhibiting NF-κB’s DNA binding, which could have a beneficial effect on Sepsis-induced immune disorders (Zgheib et al., 2017). This evidence concerns the gene NFKB1 and metabolic syndrome.